Polyomavirus BK-specific immunity after kidney transplantation

被引:98
|
作者
Comoli, P
Azzi, A
Maccario, R
Basso, S
Botti, G
Basile, G
Fontana, L
Labirio, M
Cometa, A
Poli, F
Perfumo, F
Locatelli, F
Ginevri, F
机构
[1] IRCCS, Policlin S Matteo, Lab Sperimentale Trapianto Midollo Osseo & Oncoem, I-27100 Pavia, Italy
[2] Univ Florence, Dept Publ Hlth, Florence, Italy
[3] Ist Giannina Gaslini, Pediat Nephrol Unit, I-16148 Genoa, Italy
[4] San Martino Hosp, Dept Transplant, Genoa, Italy
[5] IRCCS, Maggiore Hosp, Transplant Immunol & Blood Transfus Ctr, Milan, Italy
关键词
kidney transplantation; polyomavirus BK infection; cellular immunity; IFN-gamma-secreting lymphocytes; serology;
D O I
10.1097/01.TP.0000137932.44791.D3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Failure to mount or maintain a protective immune response may influence the development of polyomavirus BK (BKV)-associated nephropathy (PVAN). However, limited data are so far available on BKV-specific immunity after kidney transplantation. BKV-specific cellular immune response was retrospectively analyzed in kidney recipients with or without BKV infection/reactivation by measuring the frequency of interferon (IFN)-gamma-secreting cells in peripheral blood. Patients with BKV-active infection and good renal function (n=6) had a mean BKV-specific lymphocyte frequency 2 log lower than healthy controls and in the same range as BKV-seropositive recipients without active infection (n=7). Patients with PVAN (n=5) revealed undetectable levels of BKV-specific cells. However, two patients from the latter cohort treated with immunosuppression reduction showed the emergence of specific immunity, with IFN-gamma production in the same range as healthy controls. Our preliminary data suggest that lack of protective immunity toward BKV may favor the occurrence of BKV active infection and influence the progression to PVAN.
引用
收藏
页码:1229 / 1232
页数:4
相关论文
共 50 条
  • [21] Polyomavirus BK-specific CD8+T cell responses in patients after allogeneic stem cell transplant
    Schneidawind, Dominik
    Schmitt, Anita
    Wiesneth, Markus
    Mertens, Thomas
    Bunjes, Donald
    Freund, Mathias
    Schmitt, Michael
    LEUKEMIA & LYMPHOMA, 2010, 51 (06) : 1055 - 1062
  • [22] Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation
    Faguer, Stanislas
    Hirsch, Hans H.
    Kamar, Nassim
    Guilbeaud-Fruchier, Celine
    Ribes, David
    Guitard, Joelle
    Esposito, Laure
    Cointault, Olivier
    Modesto, Anne
    Mengelle, Catherine
    Durand, Dominique
    Rostaing, Lionel
    TRANSPLANT INTERNATIONAL, 2007, 20 : 205 - 205
  • [23] Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation
    Faguer, Stanislas
    Hirsch, Hans H.
    Kamar, Nassim
    Guilbeau-Frugier, Celine
    Ribes, David
    Guitard, Joelle
    Esposito, Laure
    Cointault, Olivier
    Modesto, Anne
    Lavit, Michel
    Mengelle, Catherine
    Rostaing, Lionel
    TRANSPLANT INTERNATIONAL, 2007, 20 (11) : 962 - 969
  • [24] Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation
    Evaldo Favi
    Carmelo Puliatti
    Rajesh Sivaprakasam
    Mariano Ferraresso
    Federico Ambrogi
    Serena Delbue
    Federico Gervasi
    Ilaria Salzillo
    Nicholas Raison
    Roberto Cacciola
    World Journal of Clinical Cases, 2019, 7 (03) : 270 - 290
  • [25] Reactivation of BK polyomavirus after renal transplantation
    Korth J.
    Verheyen J.
    Witzke O.
    Der Nephrologe, 2016, 11 (6): : 402 - 407
  • [26] Analysis of cellular immunity to polyomavirus BK large T and VP1 antigens after pediatric kidney transplantation.
    Comoli, Patrizia
    Basso, Sabrina
    Hirsch, Hans H.
    Azzi, Alberta
    Fontana, Iris
    Cioni, Michela
    Botti, Gerardo
    Gurrado, Antonella
    Perfumo, Francesco
    Locatelli, Franco
    Ginevri, Fabrizio
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 151 - 151
  • [27] Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy
    Radtke, Josephine
    Dietze, Nina
    Fischer, Lutz
    Achilles, Eike-Gert
    Li, Jun
    Scheidat, Silke
    Thaiss, Friedrich
    Nashan, Bjoern
    Koch, Martina
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (06) : 850 - 855
  • [28] Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation
    Wingate, Jonathan T.
    Brandenberger, Jared
    Weiss, Andrew
    Scovel, Lauren G.
    Kuhr, Christian S.
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (01)
  • [29] Urine CXCL10 to Assess BK Polyomavirus Replication After Kidney Transplantation
    Haller, Jana
    Diebold, Matthias
    Leuzinger, Karoline
    Wehmeier, Caroline
    Handschin, Joelle
    Amico, Patrizia
    Hirt-Minkowski, Patricia
    Steiger, Jurg
    Dickenmann, Michael
    Hirsch, Hans H.
    Schaub, Stefan
    TRANSPLANTATION, 2023, 107 (12) : 2568 - 2574
  • [30] Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation
    Thurid Ahlenstiel-Grunow
    Lars Pape
    Pediatric Nephrology, 2020, 35 : 375 - 382